| Item type |
学術雑誌論文 / Journal Article(1) |
| 公開日 |
2017-10-03 |
| タイトル |
|
|
タイトル |
Treatment and impact of dyslipidemia in diabetic nephropathy |
| 言語 |
|
|
言語 |
eng |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| ID登録 |
|
|
ID登録 |
10.24517/00014032 |
|
ID登録タイプ |
JaLC |
| 著者 |
Toyama, Tadashi
Shimizu, Miho
Furuichi, Kengo
Kaneko, Shuichi
Wada, Takashi
|
| 著者別表示 |
清水, 美保
古市, 賢吾
金子, 周一
和田, 隆志
|
| 書誌情報 |
Clinical and Experimental Nephrology
巻 18,
号 2,
p. 201-205,
発行日 2014-01-01
|
| ISSN |
|
|
収録物識別子タイプ |
ISSN |
|
収録物識別子 |
1342-1751 |
| NCID |
|
|
収録物識別子タイプ |
NCID |
|
収録物識別子 |
AA11126935 |
| DOI |
|
|
関連タイプ |
isVersionOf |
|
|
識別子タイプ |
DOI |
|
|
関連識別子 |
10.1007/s10157-013-0898-1 |
| 出版者 |
|
|
出版者 |
Japanese Society of Nephrology (JSN) 日本腎臓学会 / Springer Verlag (Germany) |
| 抄録 |
|
|
内容記述タイプ |
Abstract |
|
内容記述 |
Recent epidemiological research revealed that dyslipidemia is a risk factor for development and progression of diabetic nephropathy. Results from interventional studies revealed the possibility that anti-hyperlipidemic agents have a better effect on diabetic nephropathy through improvement of albuminuria and loss of renal function. In addition, dyslipidemia may be a consequence of albuminuria and renal dysfunction, thereby perpetuating kidney damage. Today, the proportion of diabetic patients receiving statins is increasing due to their beneficial effect on cardiovascular mortality. However, treatment for patients should be determined based on consideration of the risk and benefit of the treatment. More insight into the pathogenesis of diabetic nephropathy and the effects of life-style changes is required. © 2013 Japanese Society of Nephrology. |
| 権利 |
|
|
権利情報 |
The final publication is available at www.springerlink.com;http://link.springer.com/article/10.1007%2Fs10157-013-0898-1 |
| 著者版フラグ |
|
|
出版タイプ |
AM |
|
出版タイプResource |
http://purl.org/coar/version/c_ab4af688f83e57aa |
ME-PR-WADA-T-201.pdf (164.2 kB)
.png)
